Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin detemir versus NPH insulin plus insulin aspart in children and adolescents with type 1 diabetes
2006-000051-18Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Oct 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in diabetes mellitus type 1 (T1D) comparing Insulin detemir plus insulin aspart with NPH insulin plus insulin aspart (2 arms). Primary endpoint: HbA1c. Started Oct 2006; status: completed.
02
Drugs
insulin detemirhuman insulininsulin aspart
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2006-000051-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000051-18.